Technology ID
TAB-2993

Metallic Nanoparticles for Photothermal Therapy

E-Numbers
E-158-2015-0
Lead Inventor
Chen, Xiaoyuan (Shawn) (National Institute of Biomedical Imaging and Bioengineering (NIBIB/NIH))
Co-Inventors
Song, Jibin (National Institute of Biomedical Imaging and Bioengineering (NIBIB/NIH))
Applications
Therapeutics
Research Materials
Diagnostics
Consumer Products
Therapeutic Areas
Oncology
Development Stages
Pre-Clinical (in vitro)
Development Status
In vitro data available
Lead IC
NIBIB
The invention relates to the preparation and application of 20-150nm metallic nanoparticulate vesicles for photothermal anti-cancer therapy. The vesicles comprise metallic nanoparticles covalently bound to a hydrophilic and hydrophobic polymer. The preparation method generally entails dispersing a polymer-bound metallic nanoparticle in an organic solvent, adding an aqueous solution with a dispersing aid, sonicating the mixture, and finally removing the organic solvent until the vesicle forms. The final vesicle is stable wherein the metallic nanoparticle is covalently bound to the hydrophobic and hydrophilic polymer. By way of a non-limiting example, an exemplary vesicles can be one made from gold nanorods coated with polyethylene glycol and polylactic-co-glycolic acid (AuNR@PEG/PLGA) in an oil-in-water emulsion.
Commercial Applications
  • Cancer therapy
  • Tumor therapy
Competitive Advantages
  • Prolonged circulation
  • High tumor accumulation
  • Rapid excretion
  • Enhanced photoacoustic signal
  • Enhanced photothermal effect/cancer therapy efficacy
Licensing Contact:
Surabian, Karen
karen.surabian@nih.gov